As this prestigious list forms up, we at Stockhouse will highlight the companies who made the cut and will be present at the CIX Public Investor Day this November. As this is the first year for the Public Investor Day at CIX, we feel privileged to be a title sponsor of what we know will be a transformative event for everyone involved, but now onto the subject at hand.
RepliCel Life Sciences (TSX: V.RP, Forum) has been a favourite of mine for a while. This little biotech venture has big aspirations of revolutionizing the hair loss treatment market by providing what could be a permanent solution for those suffering from pattern baldness. This minimally invasive procedure will not only reintroduce healthy hair follicles, but also potentially stimulate more hair growth making for a possibly permanent reversal of hair loss. This solution is literally unheard in the industry and if RepliCel can follow through, they will become a game-changer in a sector that brought in $590 million in revenues in the United States alone in 2014.
Now, if that isn’t enough, RepliCel has a broader pipeline with solutions for both the rejuvenation of aging and sun-damaged skin as well as ground-breaking treatment for chronic tendinosis, utilizing something called NBDS fibroblast therapy. This is also not to mention the company’s development of an industry-leading patented dermal injector that can be used for a wide variety of treatments beside what’s been mentioned in this article. I think this venture has some legs and deserves your attention.
I will be sitting down with R. Lee Buckler, VP Business and Corporate Development for RepliCel, next week for an in depth piece on the company, its offering and future potential; stay tuned.
Look for more CIX Public Top 20 highlights as we draw closer to the day. Good luck to all involved!
When: November 17, 2015 (CIX), November 18, 2015 (Public Investor Day)
Where: MaRS Discovery District in Toronto
101 College Street | Toronto, ON | M5G 1L7